Back to Search
MARK STEIN, M.D.
M.D.
Allergy & Immunology Physician
NPI: 1467563494Individual
Specialties, Licenses & Credentials
Allergy & Immunology PhysicianPrimary
Allergy & Immunology
Code: 207K00000X
ME0034195(FL)
Clinical Trials (6)
6
Linked Trials
1
Recruiting
3
With Results
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
NCT03781752RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR
Sequencing Treatments for Mothers With ADHD and Their At - Risk Children
NCT01816074COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)
NCT02675400COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
NCT00183391COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
NCT02255565COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)
NCT00663442COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Sequencing Stimulant Medication and Behavioral Parent Training in Multiplex ADHD Families: A Pilot SMART.
PMID 40009046·J Clin Psychiatry·2025
2-rct
Increased Plasma Concentrations of 6-oxo-Methylphenidate inCarriers Following a Single Oral Dose of Methylphenidate.
PMID 41567292·Med Chem Res·2025
8-other
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
PMID 35201607·Cochrane Database Syst Rev·2022
1-meta
Acute Effects of Parent Stimulant Medication Versus Behavioral Parent Training on Mothers' ADHD, Parenting Behavior, and At-Risk Children.
PMID 32926603·J Clin Psychiatry·2020
4-observational
Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.
PMID 28647012·J Am Acad Child Adolesc Psychiatry·2017
4-observational
Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.
PMID 24942409·J Child Psychol Psychiatry·2015
4-observational
Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders.
PMID 17201617·J Child Adolesc Psychopharmacol·2006
8-other
ADHD symptom subtypes in children with pervasive developmental disorder.
PMID 16477513·J Autism Dev Disord·2006
8-other
Dopamine transporter genotype and methylphenidate dose response in children with ADHD.
PMID 15827573·Neuropsychopharmacology·2005
3-trial
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
PMID 16275814·Arch Gen Psychiatry·2005
4-observational
A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
PMID 14595084·Pediatrics·2003
3-trial
Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficiencies.
PMID 18814020·J Clin Immunol·2009
3-trial
Clinical immunology in practice, new opportunities.
PMID 15576892·Clin Rev Allergy Immunol·2004
6-review
Validity of DSM-IV axis V global assessment of relational functioning scale: a multimethod assessment.
PMID 19155810·J Nerv Ment Dis·2009
4-observational
Interaction of Mycoplasma genitalium with host cells: evidence for nuclear localization.
PMID 18832309·Microbiology (Reading)·2008
8-other
Possible mechanisms of influence of esophageal acid on airway hyperresponsiveness.
PMID 12928076·Am J Med·2003
7-preclinical
ADH1A variation predisposes to personality traits and substance dependence.
PMID 19526455·Am J Med Genet B Neuropsychiatr Genet·2010
8-other
Enzootic activity of pixuna and Rio Negro viruses (Venezuelan equine encephalitis complex) in a neotropical region of Argentina.
PMID 19402767·Vector Borne Zoonotic Dis·2010
7-preclinical
Treatment for anxiety disorders: Efficacy to effectiveness to implementation.
PMID 19632667·Behav Res Ther·2009
6-review
Adequacy of testing, empiric treatment, and referral for adult male emergency department patients with possible chlamydia and/or gonorrhoea urethritis.
PMID 19625583·Int J STD AIDS·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 840 US HIGHWAY 1, SUITE 235
NORTH PALM BEACH, FL 33408 - Phone
- (561) 626-2006
Quick Facts
- NPI
- 1467563494
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile